8,367-share RSU grant boosts Exelixis (NASDAQ: EXEL) director holdings

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Freire Maria C reported acquisition or exercise transactions in this Form 4 filing.

EXELIXIS, INC. director Maria C. Freire received a grant of 8,367 restricted stock units (RSUs) on May 27, 2026 under the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU equals one share of common stock and will vest 100% on May 27, 2027, subject to her continuous service. After this award, she directly holds 109,186 shares of common stock, including the shares underlying these RSUs.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Freire Maria C

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,367	$0.00	--

Holdings After Transaction: Common Stock — 109,186 shares (Direct, null)

Footnotes (1)

Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Key Figures

RSUs granted: 8,367 RSUs Post-grant holdings: 109,186 shares Grant vesting date: May 27, 2027 +1 more

4 metrics

RSUs granted 8,367 RSUs Awarded May 27, 2026 under 2017 Equity Incentive Plan

Post-grant holdings 109,186 shares Total direct common stock holdings after transaction

Grant vesting date May 27, 2027 RSUs vest 100% on this date, subject to service

Grant price per share $0.0000 per share RSU award granted at no purchase price

Key Terms

restricted stock units ("RSUs"), Exelixis, Inc. 2017 Equity Incentive Plan, economic equivalent, continuous service

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Exelixis, Inc. 2017 Equity Incentive Plan financial

"granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan"

economic equivalent financial

"Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock"

continuous service financial

"The RSUs will vest as to 100% ... subject to the Reporting Person's continuous service through that date"

Form 4 Insider Transactions: What Each Field Means →

05/29/2026 - 05:43 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Freire Maria C

(Last)

(First)

(Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA

CALIFORNIA

94502

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/27/2026		A		8,367⁽¹⁾	A	$0	109,186⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date.

2. Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did EXEL (Exelixis) report for Maria C. Freire?

Exelixis reported that director Maria C. Freire received a grant of 8,367 restricted stock units on May 27, 2026. This is a stock-based compensation award rather than an open-market share purchase or sale.

How many RSUs did Exelixis (EXEL) grant to director Maria C. Freire?

Exelixis granted Maria C. Freire 8,367 restricted stock units, each equivalent to one share of common stock. These RSUs represent additional stock-based compensation and increase her overall equity exposure to the company.

When do Maria C. Freire’s Exelixis (EXEL) RSUs vest?

Maria C. Freire’s 8,367 Exelixis RSUs will vest 100% on May 27, 2027. Vesting is conditioned on her continuous service with the company through that date, aligning the award with long-term board tenure.

What are Maria C. Freire’s total Exelixis (EXEL) holdings after this RSU grant?

Following the RSU grant, Maria C. Freire directly holds 109,186 shares of Exelixis common stock, including shares to be issued upon RSU vesting. This figure reflects her updated direct beneficial ownership position.

Is Maria C. Freire’s Exelixis (EXEL) RSU grant an open-market stock purchase?

No, Maria C. Freire’s transaction is a compensation grant of restricted stock units at a per-share price of $0.0000. It does not involve buying shares in the open market or selling existing holdings.